Circumcision of HIV-infected men: Effects on high-risk human papillomavirus infections in a randomized trial in Rakai, Uganda

Journal of Infectious Diseases

Volumn 201, Issue 10, 2010, Pages 1463-1469

  Serwadda, David ^c,d   Wawer, Maria J ^d,e   Makumbi, Frederick ^c,d   Kong, Xiangrong ^e   Kigozi, Godfrey ^d   Gravitt, Patti ^e   Watya, Stephen ^a   Nalugoda, Fred ^d   Ssempijja, Victor ^d   Tobian, Aaron A R ^e   Kiwanuka, Noah ^c,d   Moulton, Lawrence H ^f   Sewankambo, Nelson K ^b   Reynolds, Steven J ^g,h   Quinn, Thomas C ^g,h   Oliver, Amy E ^g   Lga, Boaz ^d   Laeyendecker, Oliver ^g,h   Gray, Ronald H ^d,e  

^a MULAGO HOSPITAL   (Uganda)

^b Makerere UYniversity   (Uganda)

^c MAKERERE UNIVERSITY   (Uganda)

^d RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^e Family and Reproductive Health ^*  (United States)

^f JOHNS HOPKINS UNIVERSITY   (United States)

^g DEPARTMENT OF PATHOLOGY   (United States)

^h NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; ARTICLE; CIRCUMCISION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; GENOTYPE; HIGH RISK POPULATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; INCIDENCE; INFECTION RISK; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; UGANDA; VIRUS INFECTION; WART VIRUS; AGE DISTRIBUTION; CLASSIFICATION; DISEASE TRANSMISSION; GENETICS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; PAPILLOMA VIRUS; PAPILLOMAVIRUS INFECTION; RANDOMIZED CONTROLLED TRIAL; SEXUAL BEHAVIOR; TIME; VIROLOGY;

ADOLESCENT; ADULT; AGE DISTRIBUTION; CIRCUMCISION, MALE; GENOTYPE; HIV INFECTIONS; HUMANS; INCIDENCE; MALE; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; SEXUAL BEHAVIOR; TIME FACTORS; UGANDA; YOUNG ADULT;

EID: 77951898090     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1086/652185     Document Type: Article

References (21)

1. Auvert B, Taljaard D, Lagarde E, et al. Randomized, controlled intervention trial of male circumcision for reduction of HIV infection risk: the ANRS 1265 Trial. PLoS Med 2005;2(11): e298. doi:10.1371/ journal.pmed.0020298. Published 25 October 2005.
2. Bailey RC, Moses S, Parker CB, et al. Male circumcision for HIV prevention in young men in Kisumu, Kenya: a randomised controlled trial. Lancet 2007; 369(9562): 643-656.
3. Gray RH, Kigozi G, Serwadda D, et al. Male circumcision for HIV prevention in men in Rakai, Uganda: a randomised trial. Lancet 2007; 369(9562): 657-666.
4. UNAIDS. New data on male circumcision and HIV prevention: policy and programme implications. Montreux, Switzerland: UNAIDS, 2007
5. Kigozi G, Gray RH, Wawer MJ, et al. The Safety of Adult Male Circumcision in HIV-infected and Uninfected Men in Rakai, Uganda. PLoS Med 2008; 5(6):e116.
6. Wawer MJ, Makumbi F, Kizori G, et al. Circumcision in HIV-infected men and its effects on HIV transmission to female partners in Rakai, Uganda: a randomized trial. Lancet 2009; 374: 229-237.
7. Auvert B, Sobgnwi-Tambekou J, Cutler E, et al. Effect of male circumcision on the prevalence of high-risk human papillomavirus in young men: results of a randomized controlled trial conducted in orange farm, South Africa. J Infect Dis 2009; 199(1): 14-19.
8. Tobian AAR, Serwadda D, Quinn TC, et al. Male circumcision for the prevention of HSV-2 and HPV infections and syphilis. N Engl J Med 2009; 360(13): 1298-1309.
9. Safaeian M, Kiddugavu M, Gravitt PE, et al. Prevalence and risk factors for carcinogenic human papillomavirus infections in rural Rakai, Uganda. Sex Transm Infect 2008; 84(4): 306-311.
10. Safaeian M, Kiddugavu M, Gravitt PE, et al. Determinants of incidence and clearance of high-risk human papillomavirus infections in rural Rakai, Uganda. Cancer Epidemiol Biomarkers Prev 2008; 17(6): 1300-1307.
11. 11.BoschFX,LorinczA,MuñozN,MeijerCJ,ShahKV. Thecausalrelationbetweenhumanpapillomavirusandcervicalcancer. JClinPathol2002;55(4):244-265.(Pubitemid34293391)
12. 12. Castellsague X, Bosch FX, Muñoz N, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med 2002; 346( 15) :1105-1112. (Pubitemid 34984600)
13. Mbulawa ZZ, Coetzee D, Marais DJ, et al. Genital human papillomavirus prevalence and human papillomavirus concordance in heterosexual couples are positively associated with human immunodeficiency virus coinfection. J Infect Dis 2009; 199(10): 1514-1524.
14. de Pokomandy A, Rouleau D, Ghattas G, et al. Prevalence, clearance, and incidence of anal human papillomavirus infection in HIV-infected men: the HIPVIRG cohort study. J Infect Dis 2009; 199(7): 965-973.
15. Wawer M, Makumbi F, Kigozi G, et al. Circumcision of HIV-infected men and its effect on HIV transmission to female partners in Rakai, Uganda: a randomized controlled trial. Lancet 2009; 374: 229-237.
16. Gravitt PE, Lacey JV JR, Brinton LA, et al. Evaluation of self-collected cervicovaginal cell samples for human papillomavirus testing by polymerase chain reaction. Cancer Epidemiol Biomarkers Prev 2001; 10(2): 95-100.
17. Gravitt PE, Peyton CL, Alessi TQ, et al. Improved amplification of genital human papillomaviruses. J Clin Microbiol 2000; 38(1): 357-361.
18. Gravitt PE, Peyton CL, Apple RJ, Wheeler CM. Genotyping of 27 human papillomavirus types by using L1 consensus PCR products by a single-hybridization, reverse line blot detection method. J Clin Microbiol 1998; 36(10): 3020-3027.
19. Giuliano AR, Nielson CM, Flores R, et al. The optimal anatomic sites for sampling heterosexual men for human papillomavirus (HPV) detection: the HPV detection in men study. J Infect Dis 2007; 196(8): 1146-1152.
20. Weaver BA, Feng Q, Kiviat N, et al. Evaluation of genital sites and sampling techniques for detection of human papillomavirus DNA in men. J Infect Dis 2004; 189(4): 677-685.
21. Smith JS, Moses S, Hudgens MG, et al. Human papillomavirus detection by penile site in young men from Kenya. Sex Transm Dis 2007; 34(11): 928-934.